Genetic Disease Diagnostic Market

Hereditary diseases are those caused by changes in genetic material or controlled by disease-causing genes. Hereditary diseases refer to diseases that are determined wholly or partly by genetic factors, usually congenital or acquired. Be like congenital foolish model, much point to (toe), congenital deafness dumb, hemophilia, these hereditary disease decides to come on completely by genetic factor, and just after be born certain time comes on, want to pass a few years sometimes, more than ten years even ability after decades appears apparent symptom.At present, China has adopted a variety of neonatal disease screening technologies for early diagnosis and treatment of children with genetic diseases without clinical symptoms, effectively reducing the disability rate and mortality rate of children, and greatly reducing the serious harm caused by birth defects to families and society. In recent years, with the rapid development of molecular biology and genomics, genetic testing technology has become the gold standard when it comes to most of the hereditary disease diagnosis, especially in the biochemical or enzymatic method can't make a diagnosis and test results under the condition of not clear, genetic testing is an important means of diagnosis, but in the field of neonatal hereditary disease screening, genetic testing technology is not yet ripe for applications, Gene screening for neonatal deafness has been reported in China.
Genetic Disease Diagnostic Market contains market size and forecasts of Genetic Disease Diagnostic in Global, including the following market information:
Global Genetic Disease Diagnostic Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Genetic Disease Diagnostic market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Prenatal Diagnosis Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Genetic Disease Diagnostic include Abbott, PerkinElmer, Roche Diagnostics, Bio Rad, Thermo Fisher Scientific, BGI Group, Berry Genomics, Da An Gene Co., Ltd. and Illumina and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Genetic Disease Diagnostic companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Genetic Disease Diagnostic Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Genetic Disease Diagnostic Market Segment Percentages, by Type, 2021 (%)
Prenatal Diagnosis
Screening for Single Gene Genetic Disease
Preimplantation Genetic Testing
Others
Global Genetic Disease Diagnostic Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Genetic Disease Diagnostic Market Segment Percentages, by Application, 2021 (%)
Hospital
Medical Laboratory
Others
Global Genetic Disease Diagnostic Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Genetic Disease Diagnostic Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Genetic Disease Diagnostic revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Genetic Disease Diagnostic revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
PerkinElmer
Roche Diagnostics
Bio Rad
Thermo Fisher Scientific
BGI Group
Berry Genomics
Da An Gene Co., Ltd.
Illumina
CapitalBio Technology